Our History

October, 2017


National Foundation for Cancer Research collaborates with Onconetics Pharmaceuticals, Inc.

October, 2017


Onconetics Pharmaceuticals, inc. announces its admittance into San Francisco-based biotech accelerator IndieBio with funding from SOSV.

November, 2017

Global Action Platform Summit

Onconetics cofounders meet in Nashville, TN for the annual GAP summit with world leaders in Health and Innovation.

December, 2017

Miami Family Fund Conference

As VIP guests of the National Foundation for Cancer Research, Onconetics attends the Deal Flow Family Fund Summit in Miami, FL. The summit is the largest gathering of family funds in the US.

March, 2018

Proof of Concept Acheived

Onconetics demonstrats selective killing between healthy breast cells and breast cancer cells as the culmination of five months’ work at IndieBio.

March, 2018

California Life Science Association

Onconetics cofounder and COO Gabe Hithcock presents Onconetics’ pioneering gene therapy approach at IndieBio’s Demo Day to hundreds of investors.

April, 2018

Future of Cancer Therapeutics Forum

Onconetics cofounder and CEO Luke Gruenert is invited to speak as a panelist for CalTech’s 2018 Future of Cancer Therapeutics Forum, joining esteemed guests to discuss the direction of healthcare in the coming years.